Pay in 4 interest-free payments of $20.00 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Versed hydrochloride
Smiles: OC(=O)C1CCN(CC1)C1=NC=C(C=C1Cl)C(=O)NC1=NC(=C(S1)N1CCN(CC1)C1CCCCC1)C1=CC(Cl)=CS1
Smiles: CC1C=CC(=CC=1)C1C2=C(N)N=CN=C2N(CCCO)C=1C(=O)CF
Formula: C26H24N2O
Laquinimod Catalog No.:M11360-2 Versed hydrochlorideLaquinimod, also known as, is an experimental immunomodulator developed by Active Biotech and Teva. It is being investigated as an oral treatment for multiple sclerosis (MS). Laquinimod is the successor of Active Biotech's failed experimental immunomodulator linomide. Laquinimod seems to be able to reduce the MS disease activity on MRI. In 2011, Teva announced its clinical trials involving laquinimod had failed, being unable to significantly reduce
US$ 95.00
US$ 167.95
US$ 2899.50